[182 Pages Report] The Blood Glucose Testing Market size was estimated at USD 19.34 billion in 2023 and expected to reach USD 21.15 billion in 2024, at a CAGR 9.67% to reach USD 36.92 billion by 2030.
Blood glucose testing includes devices and supplies used to measure blood glucose levels in individuals with diabetes. Blood glucose testing includes glucose meters, test strips, lancets, and continuous glucose monitoring systems. The increasing prevalence of diabetes, growing awareness about the significance of glucose monitoring, and the growing adoption of self-monitoring devices are driving the adoption of blood glucose testing devices. According to International Diabetes Federation, approximately 537 million people were diagnosed with diabetes in 2021; this number is anticipated to rise to 643 million by 2030. The growing prevalence of diabetes and the global shortage of healthcare professionals (HCP) necessitates the development of new approaches to detect drastic changes in blood glucose, expanding the usage of blood glucose testing devices. However, concerns about the accuracy and precision of measurement with blood glucose testing hamper the market growth. The researchers and market players constantly focus on upgrading the blood glucose testing devices and bringing innovation to their product portfolio, creating opportunities for market growth. In addition, the recent FDA approvals for novel blood glucose testing with a fully implantable glucose sensor and compatible mobile app have encouraged market growth and offered new attractive devices for diabetic patients.
The rising acceptance of technologically advanced medical devices and the increasing prevalence of diabetes is expected to expand the need for blood glucose testing devices in the Americas. According to a recent study, there are more than 30 million diabetic patients in North America and is expected to increase to 34 million by 2027. The increasing number of start-ups in countries including the United States, Canada, and Brazil and their efforts to bring new technologies associated with blood glucose testing are expected to contribute to the market growth in the Americas. For instance, in July 2020, Medtronic PLC and Tandem Diabetes Care Inc. announced that they entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes. The increasing prevalence of diabetic patients in Asia-Pacific is creating a platform for the growth of the blood glucose testing market in Asia-Pacific. According to the International Diabetes Federation (IDF), in 2021, approximately one in every ten adults in Asia had diabetes. One in every six diabetics globally comes from India, and one in every four comes from China. Furthermore, an increase in awareness regarding diabetes preventive care is augmenting the growth of the blood glucose testing market in Asia-Pacific.
The market dynamics represent an ever-changing landscape of the Blood Glucose Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Blood Glucose Testing Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Blood Glucose Testing Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Blood Glucose Testing Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Blood Glucose Testing Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Blood Glucose Testing Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Blood Glucose Testing Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Blood Glucose Testing Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Blood Glucose Testing Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Blood Glucose Testing Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Blood Glucose Testing Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Glucose Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Glucose Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
DexCom to launch new glucose monitoring system
Dexcom's newest glucose monitoring system is set to launch and promises to revolutionize continuous monitoring for diabetics. This innovative device, developed using the latest advances in biosensing technology, allows users to track their sugar levels for up to 10 days without interruptions. It conveniently does away with the need for finger pricks and test strips and enables users to maintain a safe and consistent level of glucose control. What's more, its smartphone connectivity allows those with diabetes access to vital information from their healthcare providers in real time. Dexcom's breakthrough solution is sure to make a lasting impact on the blood glucose testing market through its novel approach and commitment to patient safety. [Published On: 2022-04-01]
Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing
Terumo Corporation, a global leader in medical technology and blood glucose testing, is a major breakthrough for the healthcare industry. This report shatters the long-standing limitations of current testing methods by dramatically increasing the accuracy and efficiency of critically important diabetes monitoring. By improving both accuracy and usability, this new development helps to protect those with diabetes, allowing them to safely monitor their sugar levels and make necessary lifestyle adjustments. With its broad spectrum capabilities, Terumo’s blood glucose testing advancements are sure to revolutionize diabetes healthcare for years to come. [Published On: 2022-03-30]
9am.health and Ascensia partner on diabetes toolkit blood glucose meter
Patients living with diabetes require a high degree of self-care to ensure their wellbeing and successful management of the condition. Leading diabetes technology provider, Ascensia Diabetes Care, has recently launched the latest advancement in blood glucose testing that makes monitoring blood sugar levels easier than ever before. Marketed as the 9AM Health - Ascensia Blood Glucose Meter, this device utilizes optimized sensors to identify and detect patterns in blood sugar levels. The intuitive design allows users to undergo a rapid and accurate testing process that provides patient-friendly results which are logged in an interactive app for easy tracking. This cutting-edge technology is helping to revolutionize blood glucose testing, making it simpler than ever before for individuals living with diabetes to monitor their condition and take control of their health. [Published On: 2022-03-24]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Glucose Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Blood Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., AgaMatrix, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Bionime Corporation, DexCom, Inc., DiaMonTech AG, F. Hoffmann-La Roche AG, GlySens Incorporated, Indigo Diabetes NV, Johnson & Johnson Services, Inc., LifeScan, Inc., Medisana GmbH, Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, OrSense Ltd., PHC Holdings Corporation, Prodigy Diabetes Care, LLC, Rossmax International Ltd., Senseonics Holdings, Inc., Sinocare Inc., Terumo Corporation, Trividia Health, Inc., and Ypsomed AG.
This research report categorizes the Blood Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Glucose Meter
- Continuous Glucose Monitoring
- Discrete Glucose Monitoring
- Lancets
- Test Strips
- Glucose Meter
- Distribution Channel
- Offline
- Online
- End-User
- Home Care
- Hospital & Clinics
- Application
- Gestational Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Blood Glucose Testing Market, by Product
- Blood Glucose Testing Market, by Distribution Channel
- Blood Glucose Testing Market, by End-User
- Blood Glucose Testing Market, by Application
- Americas Blood Glucose Testing Market
- Asia-Pacific Blood Glucose Testing Market
- Europe, Middle East & Africa Blood Glucose Testing Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 24]
- List of Tables [Total: 460]
- List of Companies Mentioned [Total: 30]
Understanding Non-Invasive Blood Glucose Testing Devices:
Non-invasive blood glucose testing devices are designed to help diabetic patients check their glucose levels without drawing blood. These devices use sensors that measure glucose levels through non-invasive methods such as transdermal or transcutaneous monitoring. Some of the most common non-invasive blood glucose testing devices include wearable sensors, radar sensors, and optical spectroscopy.
Benefits of Non-Invasive Blood Glucose Testing Devices:
Non-invasive blood glucose testing devices offer several advantages to users. First, they eliminate the need for frequent finger pricks, which can be uncomfortable and painful. They also reduce the risk of blood-borne diseases that can result from using conventional blood glucose testing devices. Additionally, since non-invasive blood glucose testing devices can be used anytime and anywhere, they provide patients with greater freedom and flexibility in their diabetes management.
The Growing Adoption of Non-Invasive Blood Glucose Testing Devices:
The rising demand for non-invasive blood glucose testing devices has led to the widespread adoption of these devices in home healthcare settings. Many diabetic patients prefer the convenience and ease of use associated with non-invasive testing, making these devices an attractive option for diabetes management. Additionally, non-invasive blood glucose testing devices are becoming increasingly affordable, making them accessible to more people.
Factors to Consider When Choosing a Non-Invasive Blood Glucose Testing Device:
When choosing a non-invasive blood glucose testing device, it is essential to consider various factors such as accuracy, ease of use, and cost. Some devices may be more accurate than others, while some may be harder to use or require more frequent calibration. It is crucial to choose a device that meets the patient’s specific needs and preferences to ensure effective management of diabetes.
The Future of Non-Invasive Blood Glucose Testing Devices:
The development of non-invasive blood glucose testing devices represents a significant milestone in diabetes management. As technology continues to improve, it is expected to see more innovative devices that make diabetes management even more comfortable and convenient for patients. Additionally, the adoption of non-invasive blood glucose testing devices is likely to increase as more people become aware of their benefits and as the devices become more affordable.
Non-invasive blood glucose testing devices are revolutionizing diabetes management by eliminating the need for frequent finger pricks and drawing blood. As these devices become increasingly affordable and accessible, more diabetic patients opt for non-invasive testing in home healthcare settings. However, when choosing a non-invasive blood glucose testing device, it is crucial to consider several factors to ensure that it meets specific needs and preferences. With constant technological advancements in the healthcare industry, it is expected to see more exciting developments in non-invasive blood glucose testing devices in the future.
- How big is the Blood Glucose Testing Market?
- What is the Blood Glucose Testing Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?